| Date Initiated by Firm | February 24, 2017 |
| Create Date | December 06, 2018 |
| Recall Status1 |
Terminated 3 on October 20, 2023 |
| Recall Number | Z-0561-2019 |
| Recall Event ID |
81378 |
| Product Classification |
Hemoglobin m - Product Code JPB
|
| Product | Cascade Abrazo c-ACT-LR Test Card
IVD FOR IN VITRO DIAGNOSTIC USE
Store at 2 to 8 C
HELENA LABORATORIES
003366
12/13(2)
FOR EXPORT ONLY |
| Code Information |
Lot Codes: 1-16-5701 Model/Catalog Number: 5701 |
| FEI Number |
1618982
|
Recalling Firm/ Manufacturer |
Helena Laboratories, Inc. 1530 Lindbergh Dr Beaumont TX 77707-4131
|
| For Additional Information Contact | Dr. Jessica Hanka 409-842-3714 Ext. 1177 |
Manufacturer Reason for Recall | Due to some cards in this lot reported to have experienced variations in results, (verified by wave form), resulting in some cards with shorter or longer times than expected. |
FDA Determined Cause 2 | Device Design |
| Action | On 02/24/2017, the firm sent an email to affected users, with a Withdrawal Notification. The firm informed the customers/distributors that Due to some cards in this lot experiencing variations in wave form, resulting in some cards with shorter or longer times than expected. The firm instructed the customers/distributors to disposes of affected lot, as a preventive quality measure. On 04/12/2017, the firm mailed formal letters to all customers.
PUBLIC CONTACT:
"Name: Dr. Jessica Jones Hanka
"Title: Technical Services Manager
"Address: 1530 Lindbergh Drive, Beaumont, TX 77707
"Telephone #: (409) 842-3714 x1177
"Email: jhanka@helena.com |
| Quantity in Commerce | 27 kits |
| Distribution | US: Products under control of Manufacturer in TX
OUS: Four International Distributors - Australia, Netherlands, Italy, and England |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|